Aloe emodin (Synonyms: Rhabarberone; 3-Hydroxymethylchrysazine)

Name: Aloe emodin
Brand: MedChemExpress
SKU: HY-N0189
Rating: 5.0 (3 reviews)

Cat. No.: HY-N0189 Pureté: 98.32%: Fiche technique
COA

SDS
Instruction de manipulation
FAQs
Technical Support

Aloe emodin (Rhabarberone) is a natural hydroxyanthraquinone with antitumor activities. aloe-emodin can bind with mTORC2 and inhibit its kinase activity. Aloe emodin exerts antiproliferation effects and induces cellular apoptosis. Aloe emodin also exhibits antiviral activity that against influenza A virus.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

CAS No. : 481-72-1

Size	Stock	Quantité

Échantillon gratuit (0.1 - 0.2 mg)	Appliquer maintenant
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO ready for reconstitution	En stock	Estimated Time of Arrival: December 31
Solution
10 mM * 1 mL in DMSO	En stock	Estimated Time of Arrival: December 31
Solid
100 mg	En stock	Estimated Time of Arrival: December 31
500 mg	En stock	Estimated Time of Arrival: December 31
1 g	Obtenir un devis
5 g	Obtenir un devis

or Bulk Inquiry

* Veuillez sélectionner la quantité avant d'ajouter des articles.

This product is a controlled substance and not for sale in your territory.

Avis client

Based on 3 publication(s) in Google Scholar

Other Forms of Aloe emodin:

Aloe emodin (Standard) In-stock

3 Publications Citing Use of MCE Aloe emodin

In Vivo Efficacy Study

Histological Imaging/Staining

ELISA

: Aloe emodin purchased from MedChemExpress. Usage Cited in: Heliyon. 2024 Jul 22;10(15):e34932. [Abstract]; Changes in body weights of mice were monitored following treatment with different doses of AE (Aloe emodin) in a mouse model of colitis induced by DSS.

: Aloe emodin purchased from MedChemExpress. Usage Cited in: Heliyon. 2024 Jul 22;10(15):e34932. [Abstract]; Aloe emodin (5,10,50 mg/mL). H&E staining of colon tissue sections. Histological evaluation of H&E-stained colon tissue sections to assess tissue damage and inflammation.

: Aloe emodin purchased from MedChemExpress. Usage Cited in: Heliyon. 2024 Jul 22;10(15):e34932. [Abstract]; Aloe emodin (5, 10, 50 mg/kg). Serum levels of inflammatory cytokines IL-17 and TNF-α were detected by ELISA.

Recommandations en vedette

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Voir tous les produits spécifiques à Isoform mTOR:

Voir toutes les isoformes

mTOR mTORC1 mTORC2

Activité biologique
Pureté et documentation
Références
Avis client

Description

Aloe emodin (Rhabarberone) is a natural hydroxyanthraquinone with antitumor activities. aloe-emodin can bind with mTORC2 and inhibit its kinase activity. Aloe emodin exerts antiproliferation effects and induces cellular apoptosis^[1]. Aloe emodin also exhibits antiviral activity that against influenza A virus^[2].

IC₅₀ & Target^[1]

mTORC2

Cellular Effect

Cell Line	Type	Value	Description	References
A2780	IC₅₀	26 3 Compound: 2	Cytotoxicity against human A2780 cells Cytotoxicity against human A2780 cells	[PMID: 24326280]
B16-F10	IC₅₀	3.12 3 Compound: 1	Anticancer activity against mouse B16-F10 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay Anticancer activity against mouse B16-F10 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay	[PMID: 34124677]
A2780	IC₅₀	26 3 Compound: 2	Cytotoxicity against human A2780 cells Cytotoxicity against human A2780 cells	[PMID: 24326280]
B16-F10	IC₅₀	3.12 3 Compound: 1	Anticancer activity against mouse B16-F10 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay Anticancer activity against mouse B16-F10 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay	[PMID: 34124677]
HCT-116	IC₅₀	8.7 3 Compound: 4	Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay	[PMID: 17949858]
B16-F10	IC₅₀	3.12 3 Compound: 1	Anticancer activity against mouse B16-F10 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay Anticancer activity against mouse B16-F10 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay	[PMID: 34124677]
HCT-116	IC₅₀	8.7 3 Compound: 4	Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay	[PMID: 17949858]
HEK293	IC₅₀	1 3 Compound: 1	Cytotoxicity against human HEK293 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay Cytotoxicity against human HEK293 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay	[PMID: 34124677]
HEK293	IC₅₀	1 3 Compound: 1	Cytotoxicity against human HEK293 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay Cytotoxicity against human HEK293 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay	[PMID: 34124677]
HepG2	IC₅₀	10 3 Compound: 4	Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay	[PMID: 17949858]
HCT-116	IC₅₀	8.7 3 Compound: 4	Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay	[PMID: 17949858]
HepG2	IC₅₀	6.13 3 Compound: 1	Anticancer activity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay Anticancer activity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay	[PMID: 34124677]
HepG2	IC₅₀	6.13 3 Compound: 1	Anticancer activity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay Anticancer activity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay	[PMID: 34124677]
Huh-7	CC₅₀	> 50 3 Compound: 25	Cytotoxicity against human Huh7.5.1 cells by MTT assay Cytotoxicity against human Huh7.5.1 cells by MTT assay	[PMID: 22445328]
HEK293	IC₅₀	1 3 Compound: 1	Cytotoxicity against human HEK293 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay Cytotoxicity against human HEK293 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay	[PMID: 34124677]
HepG2	IC₅₀	10 3 Compound: 4	Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay	[PMID: 17949858]
Huh-7	EC₅₀	20.8 3 Compound: 25	Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay	[PMID: 22445328]
HepG2	IC₅₀	10 3 Compound: 4	Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay	[PMID: 17949858]
HepG2 2.2.15	IC₅₀	300 6 Compound: 54	Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV DNA production Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV DNA production	[PMID: 24549242]
MCF7	IC₅₀	> 20 3 Compound: AE	Cytotoxicity against human MCF7 cells after 24 hrs by XTT assay Cytotoxicity against human MCF7 cells after 24 hrs by XTT assay	[PMID: 24900344]
HepG2	IC₅₀	6.13 3 Compound: 1	Anticancer activity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay Anticancer activity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay	[PMID: 34124677]
Huh-7	CC₅₀	>50 3 Compound: 25	Cytotoxicity against human Huh7.5.1 cells by MTT assay Cytotoxicity against human Huh7.5.1 cells by MTT assay	[PMID: 22445328]
HepG2 2.2.15	IC₅₀	300 6 Compound: 54	Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV DNA production Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV DNA production	[PMID: 24549242]
Huh-7	EC₅₀	20.8 3 Compound: 25	Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay	[PMID: 22445328]
MCF7	IC₅₀	4.14 3 Compound: 1	Anticancer activity against human MCF-7 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay Anticancer activity against human MCF-7 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay	[PMID: 34124677]
HepG2 2.2.15	IC₅₀	300 6 Compound: 54	Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV e antigen secretion Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV e antigen secretion	[PMID: 24549242]
MCF7	IC₅₀	4.14 3 Compound: 1	Anticancer activity against human MCF-7 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay Anticancer activity against human MCF-7 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay	[PMID: 34124677]
MDA-MB-231	IC₅₀	12.24 3 Compound: 1	Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay	[PMID: 34124677]
HepG2 2.2.15	IC₅₀	300 6 Compound: 54	Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV surface antigen secretion Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV surface antigen secretion	[PMID: 24549242]
MCF7	IC₅₀	>20 3 Compound: AE	Cytotoxicity against human MCF7 cells after 24 hrs by XTT assay Cytotoxicity against human MCF7 cells after 24 hrs by XTT assay	[PMID: 24900344]
MOLT-4	IC₅₀	> 20 3 Compound: AE	Cytotoxicity against human MOLT4 cells after 24 hrs by XTT assay Cytotoxicity against human MOLT4 cells after 24 hrs by XTT assay	[PMID: 24900344]
OVCAR-3	IC₅₀	> 20 3 Compound: AE	Cytotoxicity against human OVCAR3 cells after 24 hrs by XTT assay Cytotoxicity against human OVCAR3 cells after 24 hrs by XTT assay	[PMID: 24900344]
Huh-7	CC₅₀	> 50 3 Compound: 25	Cytotoxicity against human Huh7.5.1 cells by MTT assay Cytotoxicity against human Huh7.5.1 cells by MTT assay	[PMID: 22445328]
MDA-MB-231	IC₅₀	12.24 3 Compound: 1	Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay	[PMID: 34124677]
SK-OV-3	IC₅₀	> 20 3 Compound: AE	Cytotoxicity against human SKOV3 cells after 24 hrs by XTT assay Cytotoxicity against human SKOV3 cells after 24 hrs by XTT assay	[PMID: 24900344]
MOLT-4	IC₅₀	>20 3 Compound: AE	Cytotoxicity against human MOLT4 cells after 24 hrs by XTT assay Cytotoxicity against human MOLT4 cells after 24 hrs by XTT assay	[PMID: 24900344]
Huh-7	EC₅₀	20.8 3 Compound: 25	Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay	[PMID: 22445328]
OVCAR-3	IC₅₀	>20 3 Compound: AE	Cytotoxicity against human OVCAR3 cells after 24 hrs by XTT assay Cytotoxicity against human OVCAR3 cells after 24 hrs by XTT assay	[PMID: 24900344]
SK-OV-3	IC₅₀	>20 3 Compound: AE	Cytotoxicity against human SKOV3 cells after 24 hrs by XTT assay Cytotoxicity against human SKOV3 cells after 24 hrs by XTT assay	[PMID: 24900344]
MCF7	IC₅₀	4.14 3 Compound: 1	Anticancer activity against human MCF-7 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay Anticancer activity against human MCF-7 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay	[PMID: 34124677]
MCF7	IC₅₀	> 20 3 Compound: AE	Cytotoxicity against human MCF7 cells after 24 hrs by XTT assay Cytotoxicity against human MCF7 cells after 24 hrs by XTT assay	[PMID: 24900344]
MDA-MB-231	IC₅₀	12.24 3 Compound: 1	Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay	[PMID: 34124677]
MOLT-4	IC₅₀	> 20 3 Compound: AE	Cytotoxicity against human MOLT4 cells after 24 hrs by XTT assay Cytotoxicity against human MOLT4 cells after 24 hrs by XTT assay	[PMID: 24900344]
OVCAR-3	IC₅₀	> 20 3 Compound: AE	Cytotoxicity against human OVCAR3 cells after 24 hrs by XTT assay Cytotoxicity against human OVCAR3 cells after 24 hrs by XTT assay	[PMID: 24900344]
SK-OV-3	IC₅₀	> 20 3 Compound: AE	Cytotoxicity against human SKOV3 cells after 24 hrs by XTT assay Cytotoxicity against human SKOV3 cells after 24 hrs by XTT assay	[PMID: 24900344]

In Vitro

Aloe emodin (0-15 μM; 24-96 h) inhibits PC3 cell proliferation in a dose-dependent manner^[1].
Aloe emodin (0-15 μM; 24 h) inhibits the activation of mTORC2 downstream substrates, Akt and PKCα. Aloe emodin could bind with mTORC2 in cells and inhibit its kinase activity^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[1]

Cell Line:	PC3 cells
Concentration:	0 μM, 2.5 μM, 5 μM, 10 μM or 15 μM
Incubation Time:	24 h, 48 h, 72 h or 96 h
Result:	Suppressed proliferation and anchorage-independent growth of PC3 cells.

Western Blot Analysis^[1]

Cell Line:	PC3 cells
Concentration:	0 μM, 2.5 μM, 5 μM, 10 μM or 15 μM
Incubation Time:	24 h
Result:	Inhibited the activation of the downstream substrates of mTORC2, Akt and PKCα.

In Vivo

Aloe emodin (10-50 mg/kg) suppresses tumor growth by inhibiting mTOR complex2 activity^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Athymic nude mice (BALB/c nude mouse, 6 weeks old)^[1]
Dosage:	10 mg/kg, 50 mg/kg (20% PEG400 in autoclaved PBS)
Administration:	Intraperitoneal injection, five times per week; for 28 days
Result:	Exhibited tumor suppression effects in vivo in an athymic nude mouse model.

Masse moléculaire

270.24

Formule

C₁₅H₁₀O₅

CAS No.

481-72-1

Appearance

Solid

Color

Brown to orange

SMILES

O=C1C2=C(C=CC=C2O)C(C3=CC(CO)=CC(O)=C13)=O

Structure Classification

Initial Source

Livraison

Room temperature in continental US; may vary elsewhere.

Stockage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	2 years
	-20°C	1 year

Solvant et solubilité

In Vitro:

DMSO : ≥ 20.83 mg/mL (77.08 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

*"≥" means soluble, but saturation unknown.

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	3.7004 mL	18.5021 mL	37.0041 mL
5 mM	0.7401 mL	3.7004 mL	7.4008 mL
10 mM	0.3700 mL	1.8502 mL	3.7004 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

Calculateur de molarité
Calculateur de dilution

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: 2.08 mg/mL (7.70 mM); Suspended solution; Need ultrasonic

This protocol yields a suspended solution of 2.08 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: 2.08 mg/mL (7.70 mM); Suspended solution; Need ultrasonic

This protocol yields a suspended solution of 2.08 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Calculation results:

Working solution concentration: mg/mL

Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).

Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.

If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.

Pureté et documentation

Purity: 98.32%

Select Batch:

Fiche technique (277 KB) SDS (392 KB)

COA (250 KB) HNMR (266 KB) LCMS (96 KB)

Instruction de manipulation (2659 KB)

Références

[1]. Liu K, et al. Aloe-emodin suppresses prostate cancer by targeting the mTOR complex 2. Carcinogenesis. 2012 Jul;33(7):1406-11. [Content Brief]

[2]. Li SW, et al. Antiviral activity of aloe-emodin against influenza A virus via galectin-3 up-regulation. Eur J Pharmacol. 2014 Sep 5;738:125-32. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	3.7004 mL	18.5021 mL	37.0041 mL	92.5104 mL
	5 mM	0.7401 mL	3.7004 mL	7.4008 mL	18.5021 mL
	10 mM	0.3700 mL	1.8502 mL	3.7004 mL	9.2510 mL
	15 mM	0.2467 mL	1.2335 mL	2.4669 mL	6.1674 mL
	20 mM	0.1850 mL	0.9251 mL	1.8502 mL	4.6255 mL
	25 mM	0.1480 mL	0.7401 mL	1.4802 mL	3.7004 mL
	30 mM	0.1233 mL	0.6167 mL	1.2335 mL	3.0837 mL
	40 mM	0.0925 mL	0.4626 mL	0.9251 mL	2.3128 mL
	50 mM	0.0740 mL	0.3700 mL	0.7401 mL	1.8502 mL
	60 mM	0.0617 mL	0.3084 mL	0.6167 mL	1.5418 mL

Aloe emodin Related Classifications

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Aloe emodin481-72-1Rhabarberone 3-HydroxymethylchrysazinemTORInfluenza VirusApoptosisAutophagyMammalian target of RapamycinInhibitorinhibitorinhibit

Please select a local distributor ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Nom du produit			Requested Quantity *
Nom du demandeur *			Civilité
Adresse e-mail *			Numéro de téléphone *
Department			Nom de l'organisation *
City			État
Country or Region *
Remarques

Nom du produit			Lot #
Nom du demandeur *			Adresse e-mail *
Numéro de téléphone			Department *
Nom de l'organisation *			Country or Region *
Remarques

Nom
Email *

	Sorry, but the email address you supplied was invalid.

Aloe emodin (Synonyms: Rhabarberone; 3-Hydroxymethylchrysazine)

Avis client

Other Forms of Aloe emodin:

Aloe emodin Related Antibodies

3 Publications Citing Use of MCE Aloe emodin

Recommandations en vedette

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Voir tous les produits spécifiques à Isoform mTOR:

Activité biologique

Pureté et documentation

Références

Avis client

Aloe emodin Related Antibodies

Calculateur de molarité

Calculateur de dilution

Complete Stock Solution Preparation Table

Aloe emodin Related Classifications

Keywords:

Vos produits récemment consultés:

Avis client

Request for HNMR Report

SAFETY DATA SHEET (SDS)

Request for HNMR Report